Grove Biopharma

Series-A
grovebiopharma.com Biotech & Healthcare Chicago, United States
Total Funding $30M
Latest Round $30M Series-A
Last Announced Apr 23, 2025
Investors 10 Backers
Decision Makers 5 Verified

About Grove Biopharma

Grove is pioneering Bionic Biologics, a breakthrough synthetic drug modality that can penetrate cells and reach protein-protein interactions that drive disease.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Chicago, United States
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website grovebiopharma.com
Domain Registered Date Oct 30, 2019

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $30,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    grovebiopharma.com

Investors & Backers

10
DCVC Bio
DeepWork Capital
Eli Lilly
Gradiant corporation
InVivium Capital
Joseph Mansueto
Mansueto Investments
Skydeck Capital
Viva BioInnovator
Walder Ventures

Funding History

1 Round
Series-A · Apr 23, 2025

Founders & Leadership

4

Geoff Duyk

Founder

Work email & phone locked Unlock →

Paul A. Bertin

Co-Founder, President & CTO

Work email & phone locked Unlock →

Professor Nathan Gianneschi

Co-Founder, Professor

Work email & phone locked Unlock →

Yuan Zhang

Head of R&D Operations and External Research

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts